-

Cassling Partners with Radiaction Medical to Help Protect Interventional Teams from Scatter Radiation

The new partnership is set to expand availability of a revolutionary new technology

OMAHA, Neb.--(BUSINESS WIRE)--Cassling announced today it is a new strategic sales agent in various geographic territories across the United States for Radiaction Medical, the makers of a novel, FDA-cleared advanced radiation blocking technology.

The Radiaction system is the first and only advanced technology to proactively block radiation at the source, providing comprehensive, head-to-toe radiation protection to the entire interventional team. Radiaction provides an unparalleled level of protection to physicians and staff while allowing unencumbered patient care, access and service.

“Radiaction is a natural fit for a partnership with Cassling,” said Elizabeth Grieger, VP of Growth and Innovation at Cassling. “For nearly 40 years, our hospital partners, including interventional suites and catheterization labs that enhance patient outcomes, have trusted us to connect them to state-of-the-art systems.”

Grieger continued, “When we met with Radiaction, we recognized how its technology is truly a revolution in what we can do to protect providers in these settings. I’m excited that we can provide our customers with an advanced solution that is designed to protect the treating physicians, as well as everyone in the procedure room. Radiaction seamlessly integrates into procedural workflow, giving providers the protection they deserve while still enabling them to do their best work for patients.”

Traditionally, procedures completed in interventional suites and catheterization labs have required physicians and other team members in the vicinity of the patient to don heavy lead aprons to protect themselves from radiation scatter. While a good start, lead gowns still provide gaps in radiation protection and leave key areas of the body, such as the head, face, legs and arms exposed.

Radiaction’s device, however, provides full-body protection. As an accessory to existing C-arm imaging equipment, Radiaction blocks more than 90% of scatter radiation to the entire room, with up to 97% radiation scatter protection for the physician’s head, according to clinical studies. The device fully encapsulates the imaging X-ray beam, and at the touch of a button, the system dynamically deploys or retracts within seconds, accommodating any patient size, imaging angulation or location while enabling the team to maintain immediate access to their patients throughout the procedure.

Jonathan Yifat, Radiaction Medical’s CEO, is excited about the partnership’s potential: “When we seek industry partners for a collaborative effort, capabilities are important, but shared corporate values are the best indicator of a productive relationship,” he said, adding, “Cassling’s deep commitment to improving the workplace experience and safety of frontline healthcare providers makes them an obvious choice for us. We are especially eager to work with them to introduce the groundbreaking Radiaction technology to Cassling’s customers, to protect and serve the people who care for patients.”

Radiaction has received 510(k) clearance from the Food and Drug Administration (FDA) to enable compatibility with certain C-arm machines. As part of an initial agreement, Cassling will offer the system to cardiology lab customers throughout the country.

Providers interested in learning more about Radiaction can contact Jeff Weinrich, VP of Growth and Innovation Sales, Cassling, jweinrich@cassling.com, or Steve Lotz, VP of Sales, Radiaction, steve@radiactionmedical.com.

About Cassling

Cassling strengthens community healthcare through customer-centric imaging and therapeutic technology, services and solutions. From critical access hospitals and diagnostic imaging centers to large health systems and IDNs, Cassling is committed to helping healthcare organizations improve access and outcomes, create efficiencies and lower costs.

Cassling serves as a partner and strategic advisor to healthcare organizations—helping them navigate the challenges of the fast-paced, ever-changing healthcare industry. Through our partnerships, including Siemens Healthineers, Cassling offers the best of both worlds—an unprecedented level of service and local support in combination with world-class imaging technology. Our goal is to impact 350 million patient lives by 2030.

Headquartered in Omaha, Nebraska, and founded in 1984, Cassling is proud to be a family-owned company and have Midwestern values and integrity at the heart of what we do. To learn more, visit www.cassling.com.

About Radiaction

Radiaction Medical, Ltd., is revolutionizing radiation protection for interventional medical teams, focused on specialties that endure the highest rates of exposure and serious health risks. In a complete departure from current solutions that shield or clothe users to block radiation, the company developed a plug-and-play device that dynamically and proactively blocks over 90% of scatter radiation at the source, offering head-to-toe protection for everyone in the interventional suite. Radiaction has received CE Marking and FDA clearance, and it is currently being marketed in Israel, Europe, and North America.

Based in Tel Aviv, Israel, Radiaction Medical was founded by Amir Belson, MD, with lead investor InnovaHealth Partners, LP. Engineering excellence allows the company to surmount real-world challenges and limitations and make a lasting impact. To learn more about Radiaction Medical and the breakthrough Radiaction system, visit www.radiactionmedical.com.

Contacts

Radiaction Medical, Ltd. LogoRadiaction Medical, Ltd. Logo

Radiaction Medical, Ltd.


Release Versions

Contacts

Social Media Profiles
More News From Radiaction Medical, Ltd.

Radiaction Medical Appoints Christopher Barys as New US President and Chief Commercial Officer

TEL AVIV, Israel--(BUSINESS WIRE)--Radiaction Medical, LTD (“Radiaction”), a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, today announced that it has appointed industry veteran Christopher Barys to serve as its US President and Chief Commercial Officer. Barys will lead commercialization efforts and operations in the US. “In the midst of a rapidly changing healthcare environment, protection for interventiona...

Radiaction Medical Raises $12.6 Million in Series C2 Funding and Elects Christopher Barys as a New Member to Its Board of Directors

TEL AVIV, Israel--(BUSINESS WIRE)--Radiaction Medical, LTD (“Radiaction”), a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, today made two announcements. First, it has raised $12.6 million in Series C2 funding led by U.S. private equity fund InnovaHealth Partners with participation from additional co-investors. Second, the company elected Christopher Barys to serve on its Board of Directors. Barys joins the o...

Radiaction Medical Announces the Latest Food and Drug Administration 510(k) Clearance for its Novel, Automated Radiation Shield System, Highlighting U.S. Expansion

TEL AVIV, Israel--(BUSINESS WIRE)--Radiaction Medical, Ltd. (“Radiaction”), a medical device innovator dedicated to providing healthcare physicians and staff with effective radiation protection during interventional procedures, announced today it has received an additional 510(k) Clearance from the Food and Drug Administration (FDA) for its Radiation Shielding System, one that enables compatibility with the Siemens Artis family of fluoroscopy C-Arm machines. The Shield System functions as an ac...
Back to Newsroom